GLA Antikörper (C-Term) (APC)
Kurzübersicht für GLA Antikörper (C-Term) (APC) (ABIN7992372)
Target
Alle GLA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- Anti-Galactosidase alpha/Gla Antibody APC Conjugated
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- A synthetic peptide corresponding to a sequence at the C-terminus of human Galactosidase alpha/Gla.
-
Isotyp
- IgG
-
-
anti-Galactosidase, alpha (GLA) (AA 81-429) antibody
GLA Reaktivität: Human WB, IHC, IP, ICC, FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Galactosidase, alpha (GLA) (AA 81-429) antibodyGLA Reaktivität: Human WB, IHC Wirt: Maus Monoclonal C8 unconjugated
anti-Galactosidase, alpha (GLA) antibodyKO Validated GLA Reaktivität: Human WB, IP, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Galactosidase, alpha (GLA) (AA 1-80) antibodyGLA Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Galactosidase, alpha (GLA) antibodyKD Validated GLA Reaktivität: Human WB, ICC, FACS Wirt: Kaninchen Monoclonal 23GB5545 unconjugated Recombinant Antibody
anti-Galactosidase, alpha (GLA) (AA 83-112), (N-Term) antibodyGLA Reaktivität: Human WB, FACS, IF, IHC (p) Wirt: Kaninchen Polyclonal RB19115 unconjugated
anti-Galactosidase, alpha (GLA) (AA 147-371) antibodyGLA Reaktivität: Human WB, IHC, IP, ICC, FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Galactosidase, alpha (GLA) (AA 1-429) antibodyGLA Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Galactosidase, alpha (GLA) (AA 1-429) antibodyGLA Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Galactosidase, alpha (GLA) (AA 101-200) antibodyGLA Reaktivität: Human, Maus, Ratte WB, ELISA, FACS, IHC (p), IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Haltbarkeit
- 12 months
-
-
- GLA (Galactosidase, alpha (GLA))
-
Andere Bezeichnung
- GLA
-
Hintergrund
-
Background: Alpha-galactosidase is a glycoside hydrolase enzyme that encoded by the GLA gene. This gene is a homodimeric glycoprotein that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. This enzyme predominantly hydrolyzes ceramide trihexoside, and it can catalyze the hydrolysis of melibiose into galactose and glucose. A variety of mutations in this gene affect the synthesis, processing, and stability of this enzyme, which causes Fabry disease, a rare lysosomal storage disorder that results from a failure to catabolize alpha-D-galactosyl glycolipid moieties.
Gene Full Name: galactosidase alpha
-
Gen-ID
- 2717
-
UniProt
- P06280
-
Pathways
- SARS-CoV-2 Protein Interaktom
Target
-
